20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.

193

WHO

10

Research on the related policies and regulations of Chinese medicine prevention and cure
for infectious diseases Su Rui*, Han Jingdan, Fan Jiping. *TCM Development Center, China Academy of
Chinese Medical Sciences, Beijing 100700, China
Corresponding author: Fan Jiping, China Academy of Chinese Medical Sciences, 100700 Beijing, China;
Email: fanjiping5218@vip.sina.com
Abstract The fast transmission and large range of emergence of infectious diseases jeopardize human
health, social and economic development, which is a great threat to global public health. World Health
Organization for the new features of infectious diseases on the International Health Regulations was revised to
help member countries improve the ability to respond to public emergencies. Our government promptly revised
the Communicable Disease Prevention Act, enacted a series of laws and strategies to promote the establishment
of infectious disease surveillance and response systems. Chinese medicine was included in the country infectious
disease prevention and control system. After nearly 10 years of development, the prevention and treatment of
Chinese medicine on emergence of infectious diseases, the clinical medicine and research capacity of respond
infectious diseases has been significantly improved, and become an important part of our system of infectious
disease prevention and control.
Key words Emergence of infectious diseases; Chinese medicine; World Health Organization; Policies
and regulations

Emergence of infectious

diseases

2003 SARS

WHO

DOI: 10.3760/cma.j.issn.1673-4246.2015.03.001

2012ZX10004301
200907001-9
100700

Email: fanjiping5218@vip.sina.com

1
2007 WHO
21

194 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3

20 70

1 40

2004

NIDRIS

WHO

2006

2005
2007

1 2011

2007 2005

WHO 2010

2012

2011 WHO ()

354 820

21 050

223 338

9 943

4 088

23 826 496 114 449 5 772 224 589 854

76 022 1 350 639
65 549

953 275

2003

10 426

2 296

1 844

24

1 625

WHO

2003 SARS
2003 5

2004

1989

1989

SARS

37

2004

2009

20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3

195

200911

H1N1

2009 H1N1

H1N1

41

41

2010

10

2003

35

SARS

2008

2013 H7N9

H7N9

2009

1.03

196 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3

Racaniello VR. Emerging infectious diseases[J]. J Clin

Invest,2004, 113(6):796-798.

WHO. The world health report 2007-A safer future: global public
health security in the 21st century[R]. Geneva:Wold Health
Orgnization,2007.

Regulations(2005)[EB/OL].

WHO. World health statistics 2013[R]. Geneva:Wold Health

Orgnization,2013.

.
[EB/OL]. [2005-05-25]. http://www.gov.cn/banshi/2005-05/25/
content_971.htm.

.
4

WHO

[EB/OL].[2008-08-14]. http://www.moh.gov.cn/qjjys/
s8547/200808/3be5c5d8966a41b1a415b4211ec40795.shtml.

Health

http://www.who.int/ihr/publications/978924159

6664/en/.
4

WHO

International

[2008-12-23].

WHO.

. [J].
-,2011,13(5):759-762.

10

.
[N]. ,2011-07-13(3).
.
[J]. ,2011,31(9):1168-1170.

2014-06-18

Oncibauerins A B

GI500.01 g/ml111314

212133

GI5030 g/ml

15

U251UACC-62MCF-7

UACC-62

1 OncibauerinA

NCI-ADR/RES786-0NCI-H460PC-3OVCAR-3

C26H30O145662Oncibauerin B

HT29K562

C27H32O14580

UACC-62K562
GI506.83 g/ml0.5 g/ml

[Phytochemistry Letters,2014,9:141-148]